Immunity for the win
Shield up with US Clincals® StrongImmune Lactoferrin™
US Clinicals® StrongImmune™ Lactoferrin contains dual forms of lactoferrin that provide the double effect. Each capsule contains 250mg of freeze-dried Lactoferrin, which is scientifically proven to boost the effects on our immune function. Patented Biosculptor® Probiotics is added as an aid to heighten immune response and promote a healthy digestive tract.
High Purity Lactoferrin from New Zealand
Grass-Fed Bovine Milk
Singapore Patented BioSculptor® Probiotics
What is Lactoferrin?
A protein naturally present in human and cow's milk, as well as other bodily fluids such as saliva, tears, mucus, and bile.
The rate of protein synthesis declines with age. Hence, lactoferrin supplementation is needed to help heighten immune response.
Bovine lactoferrin derived from cow’s milk has similar structure as human lactoferrin which exhibits immune functions. The role of lactoferrin in the immune response is well researched.
Colostrum “The First Milk”
Colostrum is the first milk produced after a baby is born. It contains about 7x more lactoferrin than is found in milk produced later on.
Purity at Its Best
AS FEATURED IN
Asia’s Leading News Portal
The World’s Biggest Business News Platform
Additional Immune-Boosting Ingredient
The patented Biosculptor® Probiotics contains 8 well-established probiotic strains (Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus gasseri, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus). Studies have shown that it is effective in promoting bowel regularity and suppressing bacterial infections in the digestive system, which in turn helps to increase immunity.
|Serving Size: 1 Capsule||Capsules Per Container: 20|
|Amount Per Serving||% Daily Value|
|Biosculptor® Probiotics(Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus gasseri, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus)(Patent #ZL201811594604.8 & 10201913127U)||2 billion CFU||*|
|* Daily Value not established.|
Supports healthy immune response
Promotes general health & wellbeing
CONSUME AT YOUR CONVENIENCE
US Clinicals® StrongImmune™ Lactoferrin is meant to be consumed daily for protection. It is also meant to be consumed prior to traveling or attending social gatherings and interactions.
How soon will I be able to see improvements in my immune health?
While results may vary among individuals, most could expect to see beneficial effects such as failing ill less often. You are advised to take StrongImmune Lactoferrin™ consecutively for 3-6 months to achieve the best results.
Will the long-term consumption of StrongImmune Lactoferrin™ result in any side effects?
No known side effect has been observed. All ingredients in StrongImmune Lactoferrin™ are tested and approved to ensure safety, purity, and efficacy. It is therefore safe for long-term consumption at the recommended dosage.
Should I separate my consumption of StrongImmune Lactoferrin™ from other medications or caffeine beverages?
Yes, because the acidity in medications and caffeine beverages may affect the efficacy of StrongImmune Lactoferrin™. You are advised to take StrongImmune Lactoferrin™ and your medications / caffeine beverages at an interval of 1-2 hours apart.
Directions of Use:
For adults. Take 1 capsule daily.
For children below 12 years old, take half capsule daily. You may open the capsule and mix with food or drinks.
Storage: Store in a cool and dry place. Keep out of reach of children.
Precaution: If you are nursing or pregnant, taking medication, or have a medical condition, you should consult your health care specialist prior to using this product.
Made in Singapore.
US Clinicals® Safety Assurance
By Family, For Family
The US Clinicals® safety pledge
from our family to yours
Developed for and loved by our family, US Clinicals® products carry an assurance of trust, safety and efficacy for you & your loved ones.
To share quality health products, from our family to yours!
At least 3 supporting clinical studies per ingredient
Blending the best ingredients from the East and the West
Internal quality standards 20% stricter than regulatory standards
1. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19.
Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, R., Pretto, C. D., Qiao, Y., Zhang, Y., Frum, T., Kadambi, N. S., Amin, A. T., O’Meara, T. R., Spence, J. R., Huang, J., Alysandratos, K. D., Kotton, D. N., Handelman, S. K., Wobus, C. E., Weatherwax, K. J., . . . Sexton, J. Z. (2021). Proceedings of the National Academy of Sciences, 118(36), e2105815118.
2. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study.
Rosa, L., Tripepi, G., Naldi, E., Aimati, M., Santangeli, S., Venditto, F., Caldarelli, M., & Valenti, P. (2021). Journal of Clinical Medicine, 10(18), 4276.
3. The Prospect of Lactoferrin Use as Adjunctive Agent in Management of SARS-CoV-2 Patients: A Randomized Pilot Study.
Algahtani, F. D., Elabbasy, M. T., Samak, M. A., Adeboye, A. A., Yusuf, R. A., & Ghoniem, M. E. (2021). Medicina, 57(8), 842.
4. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences.
Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M. P., Iacovelli, F., Romeo, A., Falconi, M., del Vecchio, C., Franchin, E., Lia, M. S., Minieri, M., Chiaramonte, C., Ciotti, M., Nuccetelli, M., Terrinoni, A., Iannuzzi, I., Coppeda, L., Magrini, A., . . . Bianchi, L. (2021). Frontiers in Pharmacology, 12.
5. The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor.
Hu, Y., Meng, X., Zhang, F., Xiang, Y., & Wang, J. (2021). Emerging Microbes & Infections, 10(1), 317–330.
6. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro.
Salaris, C., Scarpa, M., Elli, M., Bertolini, A., Guglielmetti, S., Pregliasco, F., Blandizzi, C., Brun, P., & Castagliuolo, I. (2021). Nutrients, 13(2), 328.
7. Lactoferrin as potential supplementary nutraceutical agent in COVID-19 patients: in vitro and in vivo preliminary evidences.
Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M. P., Iacovelli, F., Romeo, A., Falconi, M., del Vecchio, C., Franchin, E., Lia, M. S., Minieri, M., Chiaramonte, C., Ciotti, M., Nuccetelli, M., Terrinoni, A., Magrini, A., Bernardini, S., Andreoni, M., . . . Bianchi, L. (2020a). Lactoferrin as Potential Supplementary Nutraceutical Agent in COVID-19 Patients: In Vitro and in Vivo Preliminary Evidences. Published.
8. The Potential of Antimicrobial Peptides as an Antiviral Therapy against COVID-19.
Elnagdy, S., & AlKhazindar, M. (2020). ACS Pharmacology & Translational Science, 3(4), 780–782.
9. Lactoferrin as an immunomodulatory and iron-binding agent: Possible clinical implication in COVID-19.
Morsi, D., Ibrahim, H., Mohamed, A., Osman, G., & Salem, M. (2020). International Journal of Cancer and Biomedical Research.
10. Liposomal Lactoferrin as Potential Preventative and Cure for COVID-19.
Serrano, G., Kochergina, I., Albors, A., Diaz, E., Oroval, M., Hueso, G., & Serrano, J. M. (2020). International Journal of Research in Health Sciences, 8(1), 08–15.
11. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
Chang, R., Ng, T. B., & Sun, W. Z. (2020). International Journal of Antimicrobial Agents, 56(3), 106118.
12. Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans.
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011). PLoS ONE, 6(8), e23710.
13. Antiviral Properties of Lactoferrin—A Natural Immunity Molecule.
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011). Molecules, 16(8), 6992–7018.
14. Therapeutic Effects of Lactoferrin in Ocular Diseases: From Dry Eye Disease to Infections.
Vagge, A., Senni, C., Bernabei, F., Pellegrini, M., Scorcia, V., Traverso, C. E., & Giannaccare, G. (2020). International Journal of Molecular Sciences, 21(18), 6668.
15. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis.
Samarasinghe, R. M., Kanwar, R. K., & Kanwar, J. R. (2014). Biomaterials, 35(26), 7522–7534.
16. Oral Administration of Lactoferrin Inhibits Inflammation and Nociception in Rat Adjuvant-Induced Arthritis.
HAYASHIDA, K. I., KANEKO, T., TAKEUCHI, T., SHIMIZU, H., ANDO, K., & HARADA, E. (2004). Journal of Veterinary Medical Science, 66(2), 149–154.
17. Efficacy and tolerability of oral lactoferrin supplementation in mild to moderate acne vulgaris: an exploratory study.
Mueller, E. A., Trapp, S., Frentzel, A., Kirch, W., & Brantl, V. (2011). Current Medical Research and Opinion, 27(4), 793–797.
18. Effects of a Bovine Lactoferrin Formulation from Cow’s Milk on Menstrual Distress in Volunteers: A Randomized, Crossover Study.
Ueno, H., Yoshise, R., Sugino, T., Kajimoto, O., & Kobayashi, T. (2016). International Journal of Molecular Sciences, 17(6), 845.
19. Effect of Lactoferrin Supplementation on Iron Deficiency Anemia in Primary School Children.
El-Khawaga, A., & Abdelmaksoud, H. (2019). International Journal of Medical Arts.
20. Efficacy of Lactoferrin Oral Administration in the Treatment of Anemia and Anemia of Inflammation in Pregnant and Non-pregnant Women: An Interventional Study.
Lepanto, M. S., Rosa, L., Cutone, A., Conte, M. P., Paesano, R., & Valenti, P. (2018). Frontiers in Immunology, 9.